Dario Benincasa

Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single‐blind, non‐inferiority trial ( STANDLOW )

Giorgia Giussani, Elisa Bianchi, Edoardo Carlando, Jacopo C. DiFrancesco et autres

it, ch (code pays fourni par la source)

Supportive Care in Brain Tumors and Quality of Life

Antonio Tanzilli, Andrea Pace, Dario Benincasa, Antonio Silvani

it (code pays fourni par la source)

Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated MGMT gene promoter: RACTAC, a phase II multicenter trial

Andrea Pace, Giuseppe Lombardi, Veronica Villani, Dario Benincasa et autres

it (code pays fourni par la source)

CTNI-38. RACTAC TRIAL: PHASE II MULTICENTRIC ITALIAN TRIAL ON REPOSITIONING OF THE ANTIPSYCHOTIC DRUG CHLORPROMAZINE AND ITS COMBINATION WITH TEMOZOLOMIDE IN MGMT UNMETHYLATED GLIOBLASTOMA PATIENTS

Andrea Pace, Giuseppe Lombardi, Veronica Villani, Dario Benincasa et autres

it (code pays fourni par la source)

P11.60.A RACTAC TRIAL: PHASE II MULTICENTRIC ITALIAN TRIAL ON REPOSITIONING OF THE ANTIPSYCHOTIC DRUG CHLORPROMAZINE AND ITS COMBINATION WITH TEMOZOLOMIDE IN MGMT UNMETHYLATED GLIOBLASTOMA PATIENTS

Andrea Pace, G Lombardi, Veronica Villani, Dario Benincasa et autres

it (code pays fourni par la source)

P08.11.A PREDICTIVE SOCIAL FACTORS ASSOCIATED TO PLACE OF DEATH IN MALIGNANT GLIOMAS

Dario Benincasa, Veronica Villani, S Focarelli, Antonio Tanzilli et autres

Pattern of care of brain tumor patients in the last months of life: analysis of a cohort of 3045 patients in the last 10 years

Andrea Pace, Valeria Belleudi, Antonio Tanzilli, Veronica Villani et autres

it, my (code pays fourni par la source)

Repurposing chlorpromazine as add-on in the adjuvant phase of first-line glioblastoma therapeutic protocol in patients carrying hypo-/un-methylated MGMT gene promoter: RACTAC, a Phase II multicenter single-arm clinical trial

Andrea Pace, Giuseppe Lombardi, Veronica Villani, Dario Benincasa et autres

it (code pays fourni par la source)

CTNI-12. PHASE II MULTICENTRIC ITALIAN TRIAL ON REPOSITIONING OF THE ANTIPSYCHOTIC DRUG CHLORPROMAZINE AND ITS COMBINATION WITH TEMOZOLOMIDE IN MGMT UNMETHYLATED GLIOBLASTOMA PATIENTS: THE RACTAC TRIAL

Andrea Pace, Giuseppe Lombardi, Silvia Matteoni, Veronica Villani et autres

it (code pays fourni par la source)

Phase II multicentric Italian trial on repositioning of the antipsychotic drug chlorpromazine and its combination with temozolomide in patients with MGMT unmethylated glioblastoma: The RACTAC trial.

Giuseppe Lombardi, Marco G. Paggi, Silvia Matteoni, Veronica Villani et autres

it (code pays fourni par la source)

Recurrent glioblastoma: which treatment? A real-world study from the Neuro-oncology Unit “Regina Elena” National Cancer Institute

Veronica Villani, Luca Prosperini, Mario Lecce, Antonio Tanzilli et autres

it, my (code pays fourni par la source)

COV-BT Ire study: safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with brain tumors

Antonio Tanzilli, Andrea Pace, Gennaro Ciliberto, Antonia Marina La Malfa et autres

my, it (code pays fourni par la source)